GraniteShares YieldBOOST Biotech ETF
BIOY
NASDAQ Global Market- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management - Leveraged
- Address
- 205 Hudson Street, 7th Floor New York NY United States of America 10013
- IPO Date
- May 5, 2026
- Website
- graniteshares.com
- Similar Companies
- Business
- GraniteShares YieldBOOST Biotech ETF (BIOY) is a sector-focused exchange-traded fund that aims to generate income by employing an options-based YieldBOOST strategy linked to leveraged biotechnology exposure; BIOY seeks to deliver elevated weekly income through selling options on leveraged ETF proxies of the biotech sector while capping upside potential and employing risk controls. The fund leverages short option premium across multiple layers of exposure to deliver higher current income, with a defined structure that prioritizes income generation over capital appreciation in typical market conditions. Main Products and Services - Core offering: BIOY, a YieldBOOST Biotech ETF, designed to generate income through an options-based strategy on biotechnology-linked leveraged exposure. - Strategy components: selling near-the-money put options on leveraged biotech ETFs, buying further out-of-the-money puts to cap downside, and distributing premiums on a weekly cadence; ongoing management includes monitoring strike levels and premium collection dynamics to balance income with risk controls. - Underlying exposure: primarily linked to the performance of biotech-focused benchmarks via leveraged ETF proxies designed to deliver magnified daily returns, subject to mechanistic constraints in the option strategy. - Risk management features: built-in caps on gains from the underlying uplift, with downside protection mechanisms that may influence net income; premiums and strike selection are designed to manage downside risk while pursuing enhanced yield. - Distribution profile: targeted weekly income distributions derived from option premiums associated with the YieldBOOST framework; the fund emphasizes income generation for investors seeking yield-oriented exposure to biotech equities. Latest Major Company Changes - Product line expansion: GraniteShares expands the YieldBOOST platform with multiple sector and fixed-income launches, including new BIOY-related and other sector-focused funds beginning trading in May 2026, reflecting a strategic shift toward diversified yield-generation templates across sectors (Biotech, Financials, Technology, and longer-duration Treasuries). - Strategic platform updates: the YieldBOOST program introduces sector-based iterations, expanding from a biotech focus to broader themes, signaling a move to broaden the income-focused ETF lineup and offer investors additional carry-through potential tied to option premium strategies. - Regulatory and product documentation activity: updated prospectuses and trust filings related to the YieldBOOST lineup are filed and publicly disclosed, reflecting ongoing governance and product-structure refinement within the GraniteShares ETF Trust family. Additional Context - Industry and segments: operates in the exchange-traded fund industry with a focus on yield-generation through options strategies; BIOY sits within the broader YieldBoost family, which deploys option-based income techniques across asset classes. - Target markets and customers: intended for income-seeking investors, including retail and institutional participants, desiring quarterly or weekly income streams linked to biotech sector exposure and related leveraged instruments. - Geographic operations: listed on U.S. exchanges and governed by GraniteShares ETF Trust; products are distributed globally through U.S.-based market infrastructure and cross-border distributors as applicable. - Founding year and headquarters: GraniteShares operates as a sponsor of ETF products established to deliver yield-enhanced strategies; headquarters and primary regulatory presence are based in the United States. - Subsidiaries or parent relationships: BIOY is part of the GraniteShares YieldBOOST ETF lineup, under the GraniteShares brand family, with the underlying platform administered by the GraniteShares ETF Trust framework. Note: BIOY and the YieldBOOST platform are positioned as income-oriented ETFs that employ options-based strategies on sector- and asset-level leveraged proxies, with BIOY specifically targeting biotechnology equity exposure and associated premium opportunities, alongside ongoing platform-wide expansion to additional sectors and fixed-income themes. SARS-CoV-2 pandemic-related considerations are not a material factor in the stated investment approach.